Search 33,000+ CME courses
Back

StatPearls, LLC

  • Adenocarcinoma, Clear Cell
  • Carcinoma
  • Diethylstilbestrol
  • Uterine Cervical Neoplasms

Clear Cell Carcinoma of the Cervix

The diagnosis and management of clear cell carcinoma of the cervix is complex, and new approaches are constantly evolving. Clear cell adenocarcinoma of the uterine cervix accounts for only 4% of all adenocarcinoma cases, and about two-thirds are associated with intrauterine diethylstilbestrol (DES) exposure. Nevertheless, cases of clear cell adenocarcinoma have been reported in both adult women and children lacking a history of DES exposure. Compared to adults who suffer from adenocarcinoma, there is a high incidence of stage III and stage IV disease in children and adolescents. The incidence of disease outside of the usual screening age for cervical cancer emphasizes the importance of clinical recognition of the disease so that timely treatment can be delivered. Given the proportion of cases identified in the pediatric and young adult population, fertility-sparing treatment has been emphasized when possible. To optimize patient survival, the clinical aspects of clear cell carcinoma of the cervix must be clearly defined, particularly regarding screening, diagnosis, and treatment. This activity describes the epidemiology, predisposing factors, clinical presentation, and management of clear cell carcinoma of the cervix and highlights the role of the interprofessional team in fostering the best possible outcomes for individuals with this condition.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABPMR — Accredited CMEUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABPMR — Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 7 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

Related courses

See all

Other providers’ courses on the same topic

More from StatPearls, LLC

See all

This provider’s courses closest to this one